Vanguard Group Inc Prime Medicine, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,801,445 shares of PRME stock, worth $37.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,801,445

Previous 4,054,911 43.07%

Holding current value

$37.6 Million

Previous $35.9 Million 13.04%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$6.35 - $9.39 $11.1 Million - $16.4 Million	1,746,534 Added 43.07%	5,801,445 $40.6 Million
Q4 2023 Feb 14, 2024	BUY	$5.59 - $9.55 $576,429 - $984,776	103,118 Added 2.61%	4,054,911 $35.9 Million
Q3 2023 Nov 14, 2023	BUY	$9.5 - $15.07 $5.86 Million - $9.3 Million	617,310 Added 18.51%	3,951,793 $37.7 Million
Q2 2023 Aug 14, 2023	BUY	$11.41 - $17.05 $28 Million - $41.8 Million	2,450,037 Added 277.01%	3,334,483 $48.9 Million
Q1 2023 May 15, 2023	BUY	$11.21 - $21.11 $133,656 - $251,694	11,923 Added 1.37%	884,446 $10.9 Million

Q4 2022 Feb 10, 2023	BUY	$16.24 - $21.12 $14.2 Million - $18.4 Million	872,523 New	872,523 $16.2 Million

Others Institutions Holding PRME

# of Institutions

119

Shares Held

62.6M

Call Options Held

57.7K

Put Options Held

66.3K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $620M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Prime Medicine, Inc. Transaction History